拜卡林通过抑制TLR4/NF-κB通路来改善间歇性囊炎/膀疼痛综合征
Debin Yang1,2, Yuwei He1, Parehe Alimu1
1Department of Urology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201800, People's Republic of China.
Naunyn-Schmiedeberg's archives of pharmacology
|November 26, 2025
概括
贝卡林 (BA) 通过在老鼠模型中减少炎症和膀损伤,有效治疗间歇性囊炎/膀疼痛综合征 (IC/BPS). 它通过抑制TLR4/NF-κB信号通路而起作用,为IC/BPS提供了潜在的新疗法.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 免疫学 免疫学 免疫学
背景情况:
- 间歇性囊炎/膀疼痛综合征 (IC/BPS) 是一种慢性疾病,治疗选择有限.
- 贝卡林 (BA) 是一种来自Scutellaria baicalensis的黄类化合物,已知具有抗炎和抗氧化作用.
- 需要进一步研究BA对IC/BPS的治疗潜力.
研究的目的:
- 调查Baicalin (BA) 在改善IC/BPS症状和组织损伤方面的疗效.
- 阐明BA在IC/BPS治疗中的潜在分子机制.
- 探索BA在IC/BPS管理中临床应用的潜力.
主要方法:
- 通过使用环胺,建立了IC/BPS的老鼠模型.
- 网络药理学,代谢学和分子对接被用来确定治疗点和途径.
- 实验验证包括西部斑分析,以确认标调节和评估炎症标志物.
主要成果:
- 在IC/BPS大鼠模型中,BA治疗显著降低了尿路频率,膀损伤和促炎细胞因子 (TNF-α,IL-6,IL-1β).
- 网络药理学和代谢学确定了TLR4/NF-κB信号通路作为一个关键目标.
- 分子对接和Western blot证实,BA通过降低关键信号分子的调节来抑制TLR4/NF-κB通路.
结论:
- 贝卡林 (BA) 在临床前模型中显示出针对IC/BPS的显著治疗效果.
- BA的抗炎机制涉及抑制TLR4/NF-κB信号通路.
- 这些发现支持BA作为IC/BPS临床治疗的有希望的候选人.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
604
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
604
Drugs for Treatment of Constipation-Predominant IBS
682
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
682
Inflammatory Bowel Disease IV: Pharmacological Management
452
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
452
Urinary Tract Infection IV: Nursing Management
407
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
407
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
236
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
236
Urinary Tract Calculi V: Nursing Management
259
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
259


